Literature DB >> 18432710

Isolation and quantitation of HIV in peripheral blood.

R A Koup1, D D Ho, G Poli, A S Fauci.   

Abstract

Quantitation of replication-competent human immunodeficiency virus (HIV) in peripheral blood of infected individuals is critical for investigations of HIV pathogenesis and therapy. In this unit, the basic protocol determines the HIV titer in seropositive blood by measuring the tissue culture infectious dose (TCID) by an end-point dilution method. A second basic protocol utilizes the PHA-stimulated T cell blasts (activated T cells) in co-culture with PBMC as described in the first basic protocol for the short-term growth of HIV in vitro. An Alternate Protocol describes the accumulative method of determining 50% tissue culture infectious dose (TCID(50)) of HIV using the Reed-Muench equation when multiple replicates of a given sample are employed in the assay. A consequence of HIV infection is the depletion of CD4(+) target cells, evidenced by syncytia formation or single-cell death; two support protocols detail the evaluation of these cytopathic effects.

Entities:  

Mesh:

Year:  2001        PMID: 18432710     DOI: 10.1002/0471142735.im1202s05

Source DB:  PubMed          Journal:  Curr Protoc Immunol        ISSN: 1934-3671


  11 in total

1.  Phenotypic analysis of HIV-1 genotypic drug-resistant isolates from China, using a single-cycle system.

Authors:  Zheng Jia; Sihong Xu; Jianhui Nie; Jingyun Li; Ping Zhong; Wenbo Wang; Youchun Wang
Journal:  Mol Diagn Ther       Date:  2011-10-01       Impact factor: 4.074

2.  HIV infection of dendritic cells subverts the IFN induction pathway via IRF-1 and inhibits type 1 IFN production.

Authors:  Andrew N Harman; Joey Lai; Stuart Turville; Shamith Samarajiwa; Lachlan Gray; Valerie Marsden; Sarah K Mercier; Sarah Mercier; Kate Jones; Najla Nasr; Arjun Rustagi; Helen Cumming; Heather Donaghy; Johnson Mak; Michael Gale; Melissa Churchill; Paul Hertzog; Anthony L Cunningham
Journal:  Blood       Date:  2011-03-16       Impact factor: 22.113

3.  Establishment and maintenance of HIV latency: model systems and opportunities for intervention.

Authors:  Matthew D Marsden; Jerome A Zack
Journal:  Future Virol       Date:  2010-01-01       Impact factor: 1.831

4.  The microvesicle component of HIV-1 inocula modulates dendritic cell infection and maturation and enhances adhesion to and activation of T lymphocytes.

Authors:  Sarah K Mercier; Heather Donaghy; Rachel A Botting; Stuart G Turville; Andrew N Harman; Najla Nasr; Hong Ji; Ulrike Kusebauch; Luis Mendoza; David Shteynberg; Kerrie Sandgren; Richard J Simpson; Robert L Moritz; Anthony L Cunningham
Journal:  PLoS Pathog       Date:  2013-10-17       Impact factor: 6.823

5.  Anti-gp120 minibody gene transfer to female genital epithelial cells protects against HIV-1 virus challenge in vitro.

Authors:  Ussama M Abdel-Motal; Phuong T N Sarkis; Thomas Han; Jeffery Pudney; Deborah J Anderson; Quan Zhu; Wayne A Marasco
Journal:  PLoS One       Date:  2011-10-21       Impact factor: 3.240

6.  Genotypic prediction of tropism of highly diverse HIV-1 strains from Cameroon.

Authors:  Christelle Mbondji-Wonje; Viswanath Ragupathy; Jiangqin Zhao; Aubin Nanfack; Sherwin Lee; Judith Torimiro; Phillipe Nyambi; Indira K Hewlett
Journal:  PLoS One       Date:  2014-11-07       Impact factor: 3.240

7.  Reliable Estimation of CD8 T Cell Inhibition of In Vitro HIV-1 Replication.

Authors:  Yinyan Xu; Ann Marie Weideman; Maria Abad-Fernandez; Katie R Mollan; Sallay Kallon; Shahryar Samir; Joanna A Warren; Genevieve Clutton; Nadia Roan; Adaora A Adimora; Nancie Archin; JoAnn Kuruc; Cindy Gay; Michael G Hudgens; Nilu Goonetilleke
Journal:  Front Immunol       Date:  2021-06-30       Impact factor: 7.561

8.  Silibinin inhibits HIV-1 infection by reducing cellular activation and proliferation.

Authors:  Janela McClure; Erica S Lovelace; Shokrollah Elahi; Nicholas J Maurice; Jessica Wagoner; Joan Dragavon; John E Mittler; Zane Kraft; Leonidas Stamatatos; Leonidis Stamatatos; Helen Horton; Stephen C De Rosa; Robert W Coombs; Stephen J Polyak
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240

9.  Productive HIV-1 infection of human cervical tissue ex vivo is associated with the secretory phase of the menstrual cycle.

Authors:  E Saba; M Origoni; G Taccagni; D Ferrari; C Doglioni; A Nava; A Lisco; J-C Grivel; L Margolis; G Poli
Journal:  Mucosal Immunol       Date:  2013-02-06       Impact factor: 7.313

10.  Identification of effective subdominant anti-HIV-1 CD8+ T cells within entire post-infection and post-vaccination immune responses.

Authors:  Gemma Hancock; Hongbing Yang; Elisabeth Yorke; Emma Wainwright; Victoria Bourne; Alyse Frisbee; Tamika L Payne; Mark Berrong; Guido Ferrari; Denis Chopera; Tomas Hanke; Beatriz Mothe; Christian Brander; M Juliana McElrath; Andrew McMichael; Nilu Goonetilleke; Georgia D Tomaras; Nicole Frahm; Lucy Dorrell
Journal:  PLoS Pathog       Date:  2015-02-27       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.